Background: The rising incidence of methicillin resistant Staph. aureus (MRSA) infections is a concern for emergency practitioners. While studies have examined MRSA in inpatients, few have focused on emergency department populations. We sought to describe predictors of MRSA skin infections in an emergency department population.
Background
Over the last decade, methicillin resistant Staphylococcus aureus (MRSA) skin infections have become increasingly prevalent in the emergency department (ED) [1, 2] . While MRSA was historically limited to intensive care unit settings and to people in close contact with hospitals, there has been a recent increase in MRSA among people who have not had contact with the health care system [3] . As the number of patients with community-acquired MRSA grows, so does the need for emergency physicians to appropriately identify and treat MRSA infections.
Importance
The prevalence of MRSA in the emergency department setting has been demonstrated as on the order of 60% in patients with culturable skin and soft tissue infections [1, 2] . A recent report on MRSA prevalence concludes by suggesting physicians should provide antibiotics to cover the pathogen [2] . Such broad coverage might not be necessary if the physician can identify those patients at risk for MRSA. While various risk factors in the ED patient have been identified [1, 2] , the utility of such information in clinical practice has yet to be considered.
Goals of this Investigation
We aim to further delineate risk factors for MRSA in the ED, and to develop a predictive model to help physicians identify those patients at risk for MRSA and those that may be treated more conservatively.
Methods

Theoretical model
The primary framework guiding our study is that MRSA is spread through skin-to-skin contact with infected individuals, unsanitary conditions, and activities placing individuals in proximity with infected persons. We therefore defined a set of variables we believed would increase the risk for MRSA, including demographics, BMI, homelessness, group or nursing home residence, incarceration, IV drug use, sexual contact, health care occupation, and recent skin infections. We additionally considered lesion characteristics as potential risk factors for MRSA (Table 1) .
Study Design and Setting
This was a prospective observational cohort study of patients presenting to the ED of an urban tertiary care center with an annual census of 86,000 patients. The majority of patients at this ED are black (57%), and 67% receive Medicaid or are uninsured. The study was approved by the local institutional review board and an NIH certificate of confidentiality was obtained. The ED provides the local justice department with health care; prisoners were included in the sample with approval from the prisoner advocate.
Selection of Participants
One investigator enrolled a convenience sample of eligible patients between August 2005 and October 2005. Patients with chief complaints of abscess, spider-bite, boil, cellulitis, or infection were targeted. Screening was by examination of triage notes, and by speaking to nurses and physicians. When a potential participant was identified, eligibility was confirmed by the treating physician through identification of a soft tissue or skin infection with culture collection being possible (i.e. spontaneous drainage or planned incision and drainage). Patients were excluded if they were under 18, if they were pregnant, if they presented to the ED on antibiotics appropriate for [4, 5] .
Patients of diminished mental capacity were included. If a patient had a legal guardian, the guardian provided consent, and the patient was asked to assent. All participants demonstrated capacity to consent by correctly answering five questions about the study after the consent document was read.
Data Collection and Processing
A questionnaire was administered to all subjects that included questions about demographics as well as presence of suspected or known risk factors (Table 1 ) [6] . Race and ethnicity was self-reported. History of close contact with others with these risk factors was obtained. Height and weight were self reported or, if unknown, measured by the investigator. Characteristics of the infection (presence of a discrete collection of purulence, the presence of surrounding cellulitis, location of the lesions, and the number of lesions) as described by the treating physician were recorded.
When the treating physician obtained a culture, results of the culture were obtained from the patient's medical record when the culture was marked "final." If the treating physician did not order a wound culture, the investigator obtained an MRSA screening culture for study purposes only. The culture was obtained preferentially from the abscess cavity during incision and drainage, but also from topical draining purulence when no incision and drainage was performed.
Cultures were collected using a Becton-Dickinson BBL CultureSwab Plus collection and transport system (BD, Franklin Lakes, NJ) and sent immediately to the microbiology lab for processing. For all cultures S.aureus was identified by colony morphology, catalase, and the Pastorex Staph-Plus coagulase test (Bio-Rad Inc., Coquette-France).
For cultures ordered by a treating physician, susceptibility testing was performed using the prompt inoculation system with MicroScan positive MIC panels following manufacturer's recommendations (MicroScan, Dade Behring Inc., West Sacramento, CA). Minimum inhibitory concentration (MIC) breakpoints and quality control were applied according to CLSI standards. For the investigatorordered culture, methicillin resistance was detected using the Oxoid Penicillin Binding Protein (PBP2a) latex agglutination kit (Oxoid Limited, Besingstoke Hampshire, England) and only the presence or absence of MRSA or no growth was reported. Sensitivity and specificity of the investigator-ordered culture when compared to a reference MIC based method is 96.9 -100% and 99.5 -100%, respectively [7] [8] [9] .
Primary Data Analysis Data are described using means and standard deviations or frequencies and proportions as appropriate. Univariable logistic regression was used to identify factors related to the presence or absence of MRSA. Variables significant at the p < 0.15 level were included in a multivariable logistic regression model, which was parsed manually based on a removal criterion of p < 0.1. Changes in the odds ratios, the Hosmer and Lemeshow goodness-of-fit, and the Akaike and Schwarze Information Criterion were considered; a large change in any one of these indicates the variable may be of importance regardless of statistical significance. The C-statistic was used as the global measure of model accuracy. The C-statistic is applied to the logistic regression model results in a similar way the Receiver Operating Characteristic (ROC) curve is applied to a diagnostic test result, and it is interpreted in the same way as the area under the ROC curve. A C-statistic of one indicates the model predicts MRSA perfectly, while a C-statistic of a half indicates the model predicts disease no better than chance. Analyses were conducted using SPSS v 13.0 (SPSS Inc., Chicago, Il).
Results
Of 187 patients enrolled, five had no culture reported by the laboratory system and were excluded from the analysis. One eligible patient refused enrollment. Five cultures returned with no growth, these were considered negative for MRSA. Cultures with multiple pathogens were considered positive if any organism was MRSA. Patients are described in Table 2 Table 3 ). The C-statistic is a measure of how well a model can predict the presence of disease, with 1 being total accuracy and 0.5 being no better than chance.
Limitations
The primary limitation of this study is the convenience sample, which may have resulted in inclusion bias from two sources. First, enrollment in the study required an investigator to be present in the emergency department and second, it required the treating physician to confirm the presence of a skin abscess or infection. We have attenuated this latter source of bias by complementing routinely obtained cultures with a MRSA screening culture when the treating physician did not order a culture. Interestingly, only 10 screening cultures were needed, suggesting physicians routinely ordered cultures for skin and soft tissue infections. We mitigated the need for treating physician referral by routinely screening the emergency department population for likely study subjects during investigator hours. However, it was not possible to minimize bias associated with presentations when the investigators were not available. Thus, we cannot be sure that the study population is representative of the emergency department population presenting with infections.
Generalizability of our findings may be limited. Different communities have different rates of MRSA positivity, and perhaps different risk factors [2, 6] . Thus results from this study conducted at a single ED may not extrapolate to other communities. Finally, our study was limited only to those infections in which a wound-site culture could be obtained. Conclusions from this study, therefore, should not be extrapolated beyond patients presenting to an Emergency Department with culturable skin infections.
Discussion
There are few prior studies of MRSA skin infections in ED populations. Our prevalence of 58% is remarkably similar to the prevalences reported by Frazee 1 and Moran 2 , and reinforces the need for emergency practitioners to consider MRSA in all skin and soft tissue infections. Equally important, however, is the need to identify those at low risk for MRSA; as many antibiotics active against MRSA have poor coverage of other skin flora, empiric treatment of an unknown skin infection would require broad spectrum antibiotics. Pathogen specific treatment may help avoid the creation of further antibiotic resistance.
We studied commonly considered risk factors for MRSA infection: diabetes, incarceration, group or nursing home residence, homelessness, immunocompromise, team sport participation, intravenous drug use, sexual preference, occupation in healthcare, and recent antibiotic use Odds ratios plus 95% confidence intervals for presence of MRSA Figure 1 Odds ratios plus 95% confidence intervals for presence of MRSA.
[6]. Additionally, we considered BMI, sexual contact, close contact with individuals with risk factors, and physical descriptors of the infection as potentially related to MRSA. Similar to other ED-based studies [1, 2] , many of these commonly accepted risk factors for MRSA were not statistically associated with MRSA in our population. This may be due to a lack of statistical power; for a categorical predictor variable, our sample size would only achieve statistical significance with 80% power if the odds ratio were relatively large, greater than about 2.5, assuming the risk factor occurred about 50% of the time in one of the two groups. Alternatively, differences between underlying study populations may explain why risks among ED patients appear to differ, perhaps because the ratio of community acquired MRSA to hospital acquired MRSA is different in the ED patients.
Age has been previously described as a risk factor for community acquired MRSA [10] . While we did not distinguish between hospital and community acquired MRSA we did find a trend towards MRSA among younger subjects, which we hypothesize to be due to most of the MRSA in our study being community acquired. The decreased risk for MRSA with increasing age is small, but additive. The difference in risk between an 18 and a 70-year-old patient with no other risk factors is 37% versus 10%. The risk among younger patients is likely related to increased participation in risky activities such as team sports rather than physiologic changes due to aging. Further studies to verify or refute this finding are warranted.
MRSA tends to be a socially transmitted organism and the majority of risk factors appear to be inter-personal interactions. As such, we raised the question of whether MRSA could be "sexually transmitted." Sexual contact as an MRSA risk factor has only recently been described [11] . We originally hypothesized that sex workers would be at increased risk for MRSA due to increased skin-to-skin contact. To avoid ethical concerns arising from asking about the exchange of sex for money, we asked for number of recent sexual partners as a surrogate. We did not show a discernable difference in risk between a patient with only one partner and a patient with multiple partners, suggesting the occurrence of sexual contact and not the frequency of sexual contact is of greatest import. Physicians might benefit from obtaining a sexual history from patients with skin and soft tissue infections prior to ascertaining which antibiotics to prescribe, if any.
Recent data suggests that the majority of MRSA infected patients get better no matter which antibiotic they are prescribed [2] , which suggests perhaps MRSA need not be identified. We contend that broad spectrum coverage for every skin infection that warrants antibiotics may hasten further drug resistance. As many of the antibiotics active against MRSA have poor coverage for other typical skin flora, risk stratification for MRSA remains important. While a mathematical prediction rule to identify high risk for MRSA positivity in an infection can be based on our multivariable model, clinically relevant diagnostic information can also be derived. For example, the likelihood ratio is 0.3 for MRSA for a patient older than 24 years, who does not live in a group home, has not had sex in the last month, and does not have a discrete collection of purulence. In other words, our data would suggest that meet- ing these criteria decreases the odds of disease to about 1/ 3 of the pre-test odds.
Conclusion
Our results suggest that MRSA is present in over half of the skin infections presenting to our urban emergency department. Age less than 24, group home residence, the presence of an abscess cavity, and sexual activity within the last month should prompt the emergency physician to increase their suspicion for MRSA, while the absence of all of these factors should decrease suspicion for MRSA.
